Letko, Brosseau & Associates Inc
Net seller this quarter
$6.77B
110
-$67.4M
37.6%
Holdings
| Company | Value | % of portfolio | % of company | POSITION CHANGE qoq % | First reported |
|---|---|---|---|---|---|
| Q2 2026 | |||||
 BNS | $294M | 4.34% | 0.27% | -3.7% | Q4 2013 |
 TD | $291M | 4.30% | 0.14% | -4.9% | Q4 2013 |
 GOOG | $287M | 4.24% | Not reported | -2.4% | Q4 2015 |
 RY | $281M | 4.15% | 0.10% | -4.7% | Q4 2013 |
 BMO | $252M | 3.73% | 0.20% | -9.7% | Q4 2013 |
 SLF | $247M | 3.65% | Not reported | -3.7% | Q4 2013 |
 MGA | $245M | 3.62% | 1.33% | -5.6% | Q4 2013 |
 MFC | $241M | 3.56% | Not reported | -1.5% | Q4 2013 |
 RCI | $209M | 3.09% | Not reported | -1.4% | Q4 2013 |
 OTEX | $196M | 2.89% | 3.65% | +13.4% | Q4 2013 |
 CM | $170M | 2.51% | 0.16% | -5.8% | Q3 2015 |
 NTR | $168M | 2.48% | 0.47% | -3.5% | Q1 2018 |
 BCE | $164M | 2.43% | 0.84% | +0.8% | Q4 2013 |
 ILMN | $146M | 2.16% | 0.55% | -2.7% | Q3 2024 |
 B | $136M | 2.01% | 0.22% | -4.7% | Q2 2025 |
 CVE | $132M | 1.95% | 0.28% | -6.7% | Q4 2013 |
 META | $126M | 1.86% | Not reported | +11.4% | Q4 2017 |
 CNI | $123M | 1.81% | 0.17% | -2.3% | Q4 2013 |
 CVS | $113M | 1.67% | 0.09% | -1.8% | Q4 2020 |
 TU | $108M | 1.60% | 0.66% | +37.4% | Q4 2013 |
 CAE | $99.7M | 1.47% | 1.24% | +27.5% | Q4 2013 |
 PFE | $99.3M | 1.47% | 0.07% | +0.9% | Q4 2013 |
 WFG | $96M | 1.42% | Not reported | +0.1% | Q1 2021 |
 ADBE | $94.3M | 1.39% | 0.12% | +20.2% | Q1 2025 |
 MSFT | $90M | 1.33% | 0.00% | +41.1% | Q4 2017 |
 STT | $89.1M | 1.32% | 0.19% | -3.5% | Q4 2013 |
 T | $86.4M | 1.28% | 0.06% | +1.3% | Q4 2013 |
 ELPC | $85.4M | 1.26% | 0.25% | -7.3% | Q1 2024 |
 C | $85.2M | 1.26% | 0.04% | -3.6% | Q4 2013 |
 GSK | $85.2M | 1.26% | 0.04% | -1.2% | Q4 2013 |
 CMCSA | $85M | 1.26% | 0.08% | +51.5% | Q4 2013 |
 SWKS | $83.7M | 1.24% | 0.82% | +35.3% | Q2 2018 |
 TTE | $82.2M | 1.21% | 0.05% | -2.3% | Q4 2013 |
 EMN | $80.3M | 1.19% | 1.05% | +0.5% | Q4 2016 |
 CRM | $79.1M | 1.17% | 0.06% | +41.5% | Q4 2025 |
 TFC | $77.3M | 1.14% | 0.13% | -1.0% | Q4 2019 |
 VZ | $73.1M | 1.08% | 0.04% | +1.4% | Q4 2013 |
 SBS | $70M | 1.03% | 0.35% | +3.2% | Q4 2013 |
 ABBV | $67.9M | 1.00% | 0.02% | -1.9% | Q1 2017 |
 FDX | $67.5M | 1.00% | 0.09% | -0.9% | Q1 2015 |
 CRUS | $65.7M | 0.97% | 0.87% | -1.6% | Q4 2017 |
 GEHC | $56.2M | 0.83% | 0.19% | Not reported | Q1 2023 |
 BAC | $55.1M | 0.81% | 0.01% | -0.8% | Q4 2013 |
 TECK | $52.1M | 0.77% | Not reported | -19.2% | Q4 2013 |
 MRNA | $50.8M | 0.75% | 0.18% | -3.2% | Q4 2023 |
 EFXT | $49M | 0.72% | 1.64% | -22.6% | Q4 2022 |
 GIL | $48.8M | 0.72% | 0.51% | New | Q2 2026 |
 GPK | $47.1M | 0.70% | 1.50% | +28.3% | Q2 2022 |
 WFC | $47M | 0.70% | 0.02% | -0.8% | Q2 2018 |
 QSR | $46.6M | 0.69% | 0.18% | -3.9% | Q4 2018 |
| Q1 2026 | |||||
| RCI | $250M | 4.02% | Not reported | -1.7% | Q4 2013 |
| BNS | $243M | 3.91% | 0.28% | -5.8% | Q4 2013 |
| GOOG | $239M | 3.85% | Not reported | -0.6% | Q4 2015 |
| TD | $234M | 3.78% | 0.15% | -8.3% | Q4 2013 |
| RY | $229M | 3.70% | 0.10% | -2.9% | Q4 2013 |
| MGA | $220M | 3.54% | 1.41% | -2.9% | Q4 2013 |
| BMO | $213M | 3.44% | 0.22% | -5.6% | Q4 2013 |
| NTR | $207M | 3.34% | 0.48% | -5.3% | Q1 2018 |
| MFC | $207M | 3.34% | Not reported | -1.8% | Q4 2013 |
| SLF | $204M | 3.29% | Not reported | +1.8% | Q4 2013 |
| BCE | $190M | 3.07% | 0.83% | +3.1% | Q4 2013 |
| OTEX | $173M | 2.79% | 3.22% | +37.1% | Q4 2013 |
| B | $158M | 2.55% | 0.23% | -15.3% | Q2 2025 |
| CVE | $151M | 2.44% | 0.30% | -4.0% | Q4 2013 |
| CM | $148M | 2.38% | 0.17% | -13.6% | Q3 2015 |
| T | $119M | 1.93% | 0.06% | -0.2% | Q4 2013 |
| PFE | $115M | 1.85% | 0.07% | +5.5% | Q4 2013 |
| META | $115M | 1.85% | Not reported | +1.1% | Q4 2017 |
| CNI | $108M | 1.74% | 0.17% | +36.0% | Q4 2013 |
| ILMN | $105M | 1.69% | 0.56% | -0.7% | Q3 2024 |
| TTE | $101M | 1.62% | 0.05% | -2.3% | Q4 2013 |
| TU | $95.3M | 1.54% | 0.48% | +9.8% | Q4 2013 |
| ELPC | $94.5M | 1.52% | 0.27% | +8.8% | Q1 2024 |
| ADBE | $93M | 1.50% | 0.09% | +68.7% | Q1 2025 |
| WFG | $92.3M | 1.49% | Not reported | +21.0% | Q1 2021 |
| EMN | $91.1M | 1.47% | 1.04% | -0.1% | Q4 2016 |
| GSK | $90.8M | 1.46% | 0.04% | -1.8% | Q4 2013 |
 INTC | $89.5M | 1.44% | 0.04% | -32.2% | Q4 2013 |
| VZ | $85.5M | 1.38% | 0.04% | -0.6% | Q4 2013 |
| CAE | $81M | 1.31% | 0.97% | -3.0% | Q4 2013 |
| CVS | $80.1M | 1.29% | 0.09% | +0.3% | Q4 2020 |
| FDX | $77.5M | 1.25% | 0.09% | -2.7% | Q1 2015 |
| TFC | $72.1M | 1.16% | 0.13% | -7.6% | Q4 2019 |
| SBS | $71.7M | 1.15% | 0.34% | +5.9% | Q4 2013 |
| C | $71.6M | 1.15% | 0.04% | -22.1% | Q4 2013 |
| STT | $68.9M | 1.11% | 0.20% | -18.5% | Q4 2013 |
| CRM | $66.6M | 1.07% | 0.04% | +10391.5% | Q4 2025 |
| CMCSA | $65.6M | 1.06% | 0.06% | +0.9% | Q4 2013 |
| CRUS | $65M | 1.05% | 0.89% | -0.2% | Q4 2017 |
| MSFT | $63.3M | 1.02% | 0.00% | +26662.6% | Q4 2017 |
| ABBV | $59.8M | 0.96% | 0.02% | -3.5% | Q1 2017 |
| TECK | $55.9M | 0.90% | Not reported | -11.0% | Q4 2013 |
 COP | $55.5M | 0.89% | 0.03% | -2.3% | Q4 2013 |
| EFXT | $53.8M | 0.87% | 2.12% | -8.4% | Q4 2022 |
| QSR | $49.4M | 0.80% | 0.19% | +10.8% | Q4 2018 |
| SWKS | $48.9M | 0.79% | 0.61% | +35.9% | Q2 2018 |
| BAC | $47.6M | 0.77% | 0.01% | -0.5% | Q4 2013 |
| WFC | $45.7M | 0.74% | 0.02% | -0.6% | Q2 2018 |
 CX | $44M | 0.71% | 0.03% | +0.5% | Q3 2019 |
 MRK | $43.1M | 0.69% | 0.01% | -3.4% | Q3 2015 |
| Q4 2025 | |||||
| BNS | $275M | 4.51% | 0.30% | -6.4% | Q4 2013 |
| GOOG | $263M | 4.30% | Not reported | -2.3% | Q4 2015 |
| TD | $259M | 4.24% | 0.16% | -9.5% | Q4 2013 |
| RCI | $250M | 4.10% | Not reported | -1.0% | Q4 2013 |
| RY | $250M | 4.10% | 0.10% | -2.4% | Q4 2013 |
| MFC | $224M | 3.66% | Not reported | -1.0% | Q4 2013 |
| BMO | $218M | 3.56% | 0.24% | -5.7% | Q4 2013 |
| MGA | $217M | 3.56% | 1.45% | -1.4% | Q4 2013 |
| SLF | $201M | 3.28% | Not reported | +0.4% | Q4 2013 |
| B | $200M | 3.28% | 0.27% | -6.4% | Q2 2025 |
| OTEX | $185M | 3.03% | 2.26% | +0.5% | Q4 2013 |
| NTR | $180M | 2.94% | 0.51% | -0.2% | Q1 2018 |
| BCE | $175M | 2.87% | 0.80% | +4.2% | Q4 2013 |
| CM | $165M | 2.69% | 0.20% | -4.2% | Q3 2015 |
| META | $131M | 2.15% | Not reported | 0.0% | Q4 2017 |
| ILMN | $113M | 1.84% | 0.56% | +0.6% | Q3 2024 |
| INTC | $110M | 1.81% | 0.06% | -1.0% | Q4 2013 |
| T | $103M | 1.68% | 0.06% | +0.7% | Q4 2013 |
| CVE | $101M | 1.65% | 0.32% | -0.9% | Q4 2013 |
| CAE | $98M | 1.60% | 1.01% | -1.0% | Q4 2013 |
| PFE | $96.6M | 1.58% | 0.07% | -4.0% | Q4 2013 |
| C | $94.6M | 1.55% | 0.05% | -1.3% | Q4 2013 |
| TU | $89.4M | 1.46% | 0.44% | +2.2% | Q4 2013 |
| CVS | $88.2M | 1.44% | 0.09% | -0.3% | Q4 2020 |
| STT | $86.2M | 1.41% | 0.24% | -2.0% | Q4 2013 |
| TFC | $83.5M | 1.37% | 0.13% | +1.9% | Q4 2019 |
| GSK | $82.1M | 1.34% | 0.04% | -0.1% | Q4 2013 |
| ADBE | $79.3M | 1.30% | 0.05% | -4.0% | Q1 2025 |
| CNI | $76.6M | 1.25% | 0.13% | Not reported | Q4 2013 |
| EMN | $76.2M | 1.25% | 1.05% | +5.5% | Q4 2016 |
 SU | $73.8M | 1.21% | 0.14% | -19.6% | Q4 2013 |
| TTE | $72.2M | 1.18% | 0.05% | Not reported | Q4 2013 |
| WFG | $71.8M | 1.17% | Not reported | +1.9% | Q1 2021 |
| VZ | $69.8M | 1.14% | 0.04% | +3.3% | Q4 2013 |
| ELPC | $69.2M | 1.13% | 0.24% | +10965.8% | Q1 2024 |
| CMCSA | $67.7M | 1.11% | 0.05% | +4.7% | Q4 2013 |
| ABBV | $65.1M | 1.07% | 0.02% | -2.0% | Q1 2017 |
| FDX | $64.6M | 1.06% | 0.10% | +3.2% | Q1 2015 |
| TECK | $58.3M | 0.95% | Not reported | -15.4% | Q4 2013 |
| BAC | $53.9M | 0.88% | 0.01% | -0.5% | Q4 2013 |
| WFC | $53.8M | 0.88% | 0.02% | -15.3% | Q2 2018 |
| CRUS | $53.4M | 0.87% | 0.88% | -0.4% | Q4 2017 |
| SBS | $52.9M | 0.87% | 0.32% | -1.4% | Q4 2013 |
| GPK | $52M | 0.85% | 1.17% | +66.3% | Q2 2022 |
| CX | $43.9M | 0.72% | 0.03% | +3.4% | Q3 2019 |
| EFXT | $43.5M | 0.71% | 2.31% | -43.4% | Q4 2022 |
| SWKS | $42.6M | 0.70% | 0.45% | -14.1% | Q2 2018 |
 IVZ | $41.4M | 0.68% | 0.35% | -1.6% | Q2 2018 |
| QSR | $41.3M | 0.68% | 0.17% | +0.6% | Q4 2018 |
| COP | $40.3M | 0.66% | 0.03% | +1.3% | Q4 2013 |
| Q3 2025 | |||||
| BNS | $257M | 4.42% | 0.32% | -1.8% | Q4 2013 |
| TD | $242M | 4.16% | 0.17% | -4.8% | Q4 2013 |
| BMO | $231M | 3.97% | 0.24% | -1.9% | Q4 2013 |
| RCI | $230M | 3.96% | Not reported | -0.9% | Q4 2013 |
| RY | $221M | 3.80% | 0.11% | -1.8% | Q4 2013 |
| OTEX | $211M | 3.63% | 2.24% | +0.1% | Q4 2013 |
| GOOG | $209M | 3.59% | Not reported | -1.1% | Q4 2015 |
| MGA | $195M | 3.36% | 1.46% | +1.8% | Q4 2013 |
| MFC | $194M | 3.33% | Not reported | -0.6% | Q4 2013 |
| SLF | $192M | 3.30% | Not reported | +16.2% | Q4 2013 |
| NTR | $171M | 2.94% | 0.51% | -0.9% | Q1 2018 |
| BCE | $165M | 2.83% | 0.77% | +24.8% | Q4 2013 |
| B | $161M | 2.76% | 0.28% | -2.3% | Q2 2025 |
| CM | $151M | 2.60% | 0.20% | -3.2% | Q3 2015 |
| META | $146M | 2.50% | Not reported | -5.5% | Q4 2017 |
| T | $116M | 1.99% | 0.06% | -1.6% | Q4 2013 |
| TU | $104M | 1.79% | 0.44% | +0.5% | Q4 2013 |
| PFE | $103M | 1.77% | 0.07% | +1.3% | Q4 2013 |
| CVE | $102M | 1.75% | 0.33% | -0.9% | Q4 2013 |
| INTC | $101M | 1.74% | 0.06% | +1.4% | Q4 2013 |
| CAE | $96.3M | 1.65% | 1.02% | -2.2% | Q4 2013 |
| SU | $86.5M | 1.49% | 0.17% | -0.9% | Q4 2013 |
| CVS | $84.1M | 1.44% | 0.09% | +0.3% | Q4 2020 |
| C | $83.4M | 1.43% | 0.05% | -15.7% | Q4 2013 |
| ADBE | $83.3M | 1.43% | 0.06% | +41.2% | Q1 2025 |
| ILMN | $81.1M | 1.39% | 0.56% | +0.1% | Q3 2024 |
| STT | $79.1M | 1.36% | 0.24% | -1.3% | Q4 2013 |
| WFG | $78.1M | 1.34% | Not reported | +2.7% | Q1 2021 |
| TFC | $76.1M | 1.31% | 0.13% | -0.5% | Q4 2019 |
| VZ | $72.9M | 1.25% | 0.04% | +0.4% | Q4 2013 |
| GSK | $72.3M | 1.24% | 0.04% | +0.9% | Q4 2013 |
| EMN | $71.4M | 1.23% | 0.99% | +33.1% | Q4 2016 |
| CMCSA | $68M | 1.17% | 0.05% | +18.4% | Q4 2013 |
| ABBV | $67.4M | 1.16% | 0.02% | -2.1% | Q1 2017 |
| TECK | $63.1M | 1.08% | Not reported | -0.8% | Q4 2013 |
| SWKS | $60.2M | 1.03% | 0.53% | +1.6% | Q2 2018 |
| WFC | $57.1M | 0.98% | 0.02% | -1.8% | Q2 2018 |
| CRUS | $56.6M | 0.97% | 0.88% | +0.7% | Q4 2017 |
| SBS | $56M | 0.96% | 0.33% | -0.3% | Q4 2013 |
| EFXT | $53.7M | 0.92% | 4.01% | -1.6% | Q4 2022 |
 HBM | $53.5M | 0.92% | 0.89% | -56.2% | Q4 2013 |
| FDX | $51.1M | 0.88% | 0.09% | +3.7% | Q1 2015 |
| BAC | $50.8M | 0.87% | 0.01% | -0.2% | Q4 2013 |
 GILD | $47M | 0.81% | 0.03% | -20.6% | Q2 2014 |
 SHEL | $45.4M | 0.78% | 0.01% | -0.1% | Q1 2022 |
 WMT | $40.9M | 0.70% | 0.01% | -2.4% | Q4 2013 |
| GPK | $40.6M | 0.70% | 0.70% | +33.6% | Q2 2022 |
| COP | $40.2M | 0.69% | 0.03% | -0.1% | Q4 2013 |
| QSR | $38.5M | 0.66% | 0.18% | +27.0% | Q4 2018 |
| IVZ | $36.7M | 0.63% | 0.36% | -0.1% | Q2 2018 |